Information processing device, information management method, computer program, and specimen collection kit

The information processing device enables offline infection status determination with user-controlled disclosure and the collection port improves specimen collection efficiency and leakage prevention, addressing connectivity and suction force issues in existing technologies.

KR1020260162279APending Publication Date: 2026-11-10UCHIDA GIKEN CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
KR1020267019076
Authority / Receiving Office
KR · KR
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-04-01
Filing Date
2025-03-31
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Existing technologies require online connectivity between information processing devices and management servers for infection status determination, leading to potential disclosure of results to third parties without user consent, and conventional blood collection devices struggle with insufficient suction force for specimen collection.

Method used

An information processing device with an acquisition unit, operation unit, notification unit, and controller allows offline determination of infection status with user control over result disclosure, and a collection port with specific hole configurations enhances sample collection efficiency and prevention of leakage.

Benefits of technology

Ensures user confidentiality in infection status determination and facilitates easy, reliable specimen collection with reduced leakage and improved volume estimation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure P1020267019076_ABST
    Figure P1020267019076_ABST
Patent Text Reader

Abstract

It is possible to obtain the result of determining the infection status offline and also select whether or not to disclose the result. The information processing device is an information processing device connected to a management server via a network and is equipped with an acquisition unit, an operation unit, a notification unit, and a controller. The controller executes an acquisition process that acquires collection information based on the user's sample collection result through the acquisition unit; a determination process that determines the user's infection status based on the collection information without transmitting the collection information to the management server; a notification process that notifies the user of the result of determining the infection status through the notification unit; an authorization reception process that receives authorization information authorizing the disclosure of the result of determining the infection status through the operation unit; and a transmission process that transmits the determination information regarding the result of determining the infection status to the management server on the condition that the authorization information is received.
Need to check novelty before this filing date? Find Prior Art

Description

Technology Field

[0001] The technology disclosed in this specification relates to an information processing device, an information management method, a computer program, and a sample collection kit. Background Technology

[0002] Conventionally, a technology has been known that allows a user, such as a test subject, to obtain a diagnostic result regarding the presence or absence of antibodies or antigens using a mobile terminal. For example, in the first technology, a camera unit formed on a mobile phone captures a judgment unit of a test subject displaying a color development state. The mobile phone transmits the obtained image data to a diagnostic server. The diagnostic server detects the presence or absence or concentration of a specific component based on the received image data and transmits diagnostic data corresponding to the detected presence or absence or concentration of the specific component to the mobile phone (see, for example, Patent Document 1). In the second technology, an antigen test terminal performs an antigen test based on an inserted immunochromatography test kit and automatically transmits the test result and the status of infection to a mobile terminal owned by the test subject (see, for example, Patent Document 2).

[0003] In addition, a blood collection device for collecting blood from a puncture site in the human body is known (see, for example, Patent Document 3). The conventional blood collection device has a capillary tube and a pressing chamber. The capillary tube has a tip portion with a small diameter and a base portion with a large diameter. The chamber is connected to an intermediate portion between the tip portion and the base portion of the capillary tube. When the chamber is pressed while the tip portion of the capillary tube is in contact with the blood coming from the puncture site, the blood is sucked from the tip portion to the base portion of the capillary tube (see, for example, Patent Document 3). Prior art literature

[0004] Japanese Published Patent Application No. 2010-190867 Japanese Published Patent Application No. 2022-115777 Japanese Published Patent Application No. 2022-161878 The problem to be solved

[0005] In the above-mentioned conventional technologies 1 and 2, there is a problem that the user cannot obtain the result of determining the infection status unless the information processing device, such as a mobile terminal owned by the user, and the management server, such as a diagnostic server, are connected online. In addition, in technology 1, there is a problem that the result of determining the user's infection status is disclosed to a third party regardless of the user's will.

[0006] Furthermore, the aforementioned conventional blood collection device is a so-called dropper-type suction device that utilizes suction force generated by the restoring force of the chamber. Consequently, the suction force is relatively weak, raising concerns that it may not be possible to collect a sufficient amount of blood for testing. This problem is not limited to blood collection but is a common issue for the collection or testing of specimens other than blood. Specimens are materials expelled from or collected from the human body, and include materials obtained through manual procedures or surgery, such as urine, feces, sputum, saliva, and abrasions, in addition to blood.

[0007] The present specification discloses a technology capable of solving at least one of the problems described above. means of solving the problem

[0008] The technology disclosed in this specification can be realized, for example, in the following forms.

[0009] (1) The information processing device disclosed in this specification is connected to a management server via a network so as to be communicable. The information processing device comprises an acquisition unit, an operation unit, a notification unit, and a controller. The controller performs an acquisition process of acquiring collection information based on the user's sample collection results through the acquisition unit, a determination process of determining the user's infection status based on the collection information without transmitting the collection information to the management server, a notification process of notifying the user of the determination result of the infection status through the notification unit, an authorization reception process of receiving authorization information that permits the disclosure of the determination result of the infection status through the operation unit, and a transmission process of transmitting the determination information regarding the determination result of the infection status to the management server on the condition that the authorization information is received. According to the information processing device, the user can obtain the determination result of the infection status offline and can also choose whether or not to disclose the determination result. Therefore, by ensuring confidentiality, the mental barrier to receiving a determination of the infection status is lowered.

[0010] (2) In the information processing device, the controller may also execute a selection reception process in which it receives selection information for selecting a target for disclosure among a plurality of different user-related information regarding the user through the operation unit, and in the transmission process, the controller may be configured to transmit the user-related information selected by the selection information to the management server in addition to the judgment information, on the condition that the permission information is received. According to the present configuration, the user can select the scope of disclosure of user-related information regarding himself.

[0011] (3) In the information processing device, the controller may be configured to notify the user of hospital information where examination is possible based on the location information when the result of determining the infection status is positive and the selection information includes the user's location information. According to this configuration, the user can obtain hospital information where examination is possible by providing their location information.

[0012] (4) In the above information processing device, the controller may also execute a designation reception process in which, when the result of determining the infection state is positive, it receives designation information through the operating unit, which designates one of at least two of obtaining infection precaution information, online communication with medical personnel, and face-to-face communication with medical personnel, and in the notification process, notify the user of information regarding communication according to the designation information. According to this configuration, the user can obtain information such as how to deal with the infection in a way that is different in terms of confidentiality.

[0013] (5) In the above information processing device, the controller may also execute a time reception process for receiving the estimated time of infection through the operating unit, and in the notification process, if the result of determining the infection state is negative, the controller may notify the user through the notification unit whether the result of determining the infection state is valid based on the estimated time. According to this configuration, the user can know that there is a possibility that the result was negative because it was not the appropriate time for determination.

[0014] (6) In the above information processing device, the acquisition unit has a camera, and the controller may be configured such that, in the acquisition process, the camera captures a test area in which a line develops color in response to a sample collected from the test kit, and acquires the image of the test area as the collection information, and in the judgment process, the image of the test area is converted into a binarized image, and the presence or absence of a line is detected based on the number of dots in the binarized image, and the infection state is determined based on the result of detecting the presence or absence of a line. According to the present configuration, the determination of the presence or absence of a line in the test kit can be performed without relying on visual inspection by a user.

[0015] (7) The collection port disclosed in this specification is a collection port for collecting a sample. The collection port comprises a tube portion having an internal space, a syringe having a receiving portion covering an opening at one end of the tube portion, and a plunger inserted into the internal space of the tube portion. A through hole is formed in the receiving portion that penetrates from the outer surface of the receiving portion to the internal space of the tube portion. The through hole includes a first hole that opens toward the outer surface of the receiving portion and a second hole located between the first hole and the internal space of the tube portion. The first area of ​​the cross-section of the first hole is larger than the second area of ​​the cross-section of the second hole, and the second area of ​​the second hole is smaller than the internal area of ​​the cross-section of the internal space of the tube portion.

[0016] In the present configuration, the first area of ​​the first hole, which is opened on the outer surface of the receiving portion, is larger than the second area of ​​the second hole. For this reason, compared to a configuration where, for example, the first area of ​​the first hole is less than or equal to the second area of ​​the second hole, it is easier to place a sample into the through hole of the receiving portion. Conversely, since the second area of ​​the second hole is smaller than the first area of ​​the first hole, it is difficult for the sample inside the first hole to move into the internal space of the container, and it is easy to determine the amount of sample collected inside the first hole. After placing the sample into the through hole, the sample inside the first hole is sucked into the internal space of the container through the second hole by the suction force generated by the plunger being pulled away from the receiving portion. Since the second area of ​​the second hole is smaller than the area of ​​the internal space of the container, it is possible to suppress the backflow of the sample that has moved into the internal space into the first hole. In this way, according to the present configuration, ease of sample collection, estimation of the sample volume, and prevention of leakage of the collected sample can be achieved.

[0017] (8) In the above-mentioned collection port, the first hole may be configured such that the cross-sectional area is expanded from the side of the second hole toward the side of the outer surface of the receiving portion. According to this configuration, for example, compared to a configuration where the cross-sectional area of ​​the first hole is constant, it is easier to insert the sample into the through hole (first hole).

[0018] (9) In the above-mentioned collection port, the through hole also includes a third hole located between the first hole and the outer surface of the receiving portion, and the expansion rate of the third hole may be configured differently from the expansion rate of the first hole. According to this configuration, a receiving space for the buffer solution is secured, and the boundary between the first hole and the third hole is also easy to see.

[0019] (10) The above sample collection kit may be configured to include a collection port and a cartridge having a receiving space for receiving a test kit. The cartridge has a connecting part connected to the receiving part of the collection port. The connecting part has a connecting hole formed therein that communicates with the first hole of the connected receiving part and also communicates with the receiving space of the cartridge. According to the present configuration, the collection port can be connected to the cartridge and the plunger of the collection port can be pushed in to load the sample inside the container into the test kit.

[0020] (11) In the above sample collection kit, the through hole may also be configured to include a fourth hole located between the first hole and the outer surface of the receiving portion. The fourth hole is opened so that the cross-sectional area expands from the side of the first hole toward the side of the outer surface of the receiving portion. The connecting portion of the cartridge has a contact portion that contacts the inner surface of the fourth hole of the through hole over its entire circumference. According to the present configuration, leakage of the sample or air can be suppressed by the close contact between the inner surface of the fourth hole and the contact portion.

[0021] In addition, the technology disclosed in this specification can be realized in various forms, for example, in the form of a collection port, a blood collection port, a specimen collection kit, a blood collection kit, a receiving member (attachment) formed in a syringe, an information processing device, a reader, an infection determination device, an information management method, an information management program, an infection determination method, an infection determination program, etc. Brief explanation of the drawing

[0022] FIG. 1 is a perspective view schematically showing the overall configuration of a blood collection kit (1) in the first embodiment. FIG. 2 is an explanatory diagram showing the configuration of the longitudinal section of the blood collection cell (100). FIG. 3 is an explanatory diagram showing the configuration of the side of the attachment (30). FIG. 4 is an explanatory diagram showing the configuration of the longitudinal section of the attachment (30). FIG. 5 is an explanatory diagram showing the configuration of the plane of the attachment (30). FIG. 6 is a perspective view showing the external configuration of the cartridge (200). Figure 7 is an explanatory diagram showing the change in the state of the blood collection cell (100) at the time of blood collection. FIG. 8 is an explanatory diagram showing the connection process between the blood collection cell (100) and the cartridge (200). FIG. 9 is an explanatory diagram showing the state after the transfer of blood (B) from the blood collection cell (100) to the cartridge (200). FIG. 10 is an explanatory diagram showing the configuration of an information management system in a second embodiment. FIG. 11 is a top view showing the external configuration of the cartridge and the reader. FIG. 12 is a cross-sectional view showing the internal configuration of the cartridge and the reader. FIG. 13 is a top view showing the configuration of the cartridge body. FIG. 14 is a perspective view showing the configuration of a cartridge cap. Fig. 15 is a side view showing the configuration of the cartridge cap. FIG. 16 is a cross-sectional view showing an enlarged view of the front portion of the cartridge in FIG. 12. Figure 17 is an explanatory diagram showing the usage process of the cartridge. Figure 18 is a flowchart showing the infection determination process. FIG. 19 is an explanatory diagram showing the detection process of the presence or absence of a line on an immunochromatographic test specimen. FIG. 20 is an explanatory diagram showing the screen display of a mobile terminal. Specific details for implementing the invention

[0023] A. First embodiment:

[0024] A-1. Composition of blood collection kit (1):

[0025] FIG. 1 is a perspective view schematically showing the overall configuration of a blood collection kit (1) in the first embodiment of the present invention. The blood collection kit (1) is an example of a sample collection kit. The blood collection kit (1) is used for sample testing to determine the presence or absence of a specific disease by collecting blood (B) (see FIG. 7 described later) from the human body and dropping the blood (B) onto an immunochromatographic test specimen. In addition, immunochromatography (immunochromatography method) is a testing method that determines the presence or absence of antibodies or antigens using an antigen-antibody reaction. The blood collection kit (1) enables an individual to properly and safely perform a series of operations from collecting blood (B) to dropping the blood (B) onto an immunochromatographic test specimen at home, etc., without relying on experts such as medical personnel.

[0026] As shown in FIG. 1, the blood collection kit (1) is equipped with a blood collection tube (100) and a cartridge (200). The blood collection tube (100) is a device for collecting blood (B) from a puncture site of the human body. The blood collection tube (100) is an example of a collection tube, and the blood (B) is an example of a specimen. The cartridge (200) is a case for holding an immunochromatographic test specimen. FIG. 1 shows the blood collection tube (100) and the cartridge (200) connected.

[0027] (Composition of blood cells (100)) :

[0028] FIG. 2 is an explanatory diagram showing the configuration of a longitudinal section of a blood collection tube (100). In this specification, "longitudinal section" refers to a cross-section along the longitudinal direction (up-down direction of the ground in FIG. 1 and FIG. 2) of the blood collection tube (100) (syringe (10) described later), and "transverse section" refers to a cross-section perpendicular to the same longitudinal direction. As shown in FIG. 1 and FIG. 2, the blood collection tube (100) is equipped with a syringe (10) and a plunger (20). The syringe (10) may also be called an injection tube or an outer tube. The plunger (20) may also be called a pusher.

[0029] The syringe (10) has a tube (11) and an attachment (30). The syringe (10) is preferably formed of a light-transmitting material (glass, resin, etc.), for example. The attachment (30) is an example of a receiving portion. The attachment (30) is formed on one end side in the longitudinal direction of the tube (11). Hereinafter, among the syringe (10) (tube (11)), the side of the attachment (30) is referred to as the "tip side," and the side opposite to the attachment (30) is referred to as the "base side."

[0030] The tube (11) is a cylindrical body that extends in a straight line overall. The tube (11) has a barrel (15) and a lure (16) located at the tip of the barrel (15) (see FIG. 2). The barrel (15) is a part that extends from the base of the tube (11) toward the tip (in the direction below the ground in FIG. 1 and FIG. 2), and the lure (16) is a part that extends from the tip of the tube (11) toward the base (in the direction above the ground in FIG. 1 and FIG. 2). The outer diameter of the barrel (15) is larger than the outer diameter of the lure (16).

[0031] The barrel space (15A), which is the internal space of the barrel (15), extends in a straight line along the longitudinal direction of the tube (11). The barrel space (15A) is a cylindrical space of the same diameter along the entire length in the longitudinal direction. The lure space (16A), which is the internal space of the lure (16), extends in a straight line along the longitudinal direction of the tube (11). The lure space (16A) is a cylindrical space of the same diameter along the entire length in the longitudinal direction. The tip of the barrel space (15A) and the base of the lure space (16A) are connected. The inner diameter of the lure space (16A) is smaller than the inner diameter of the barrel space (15A), and a step (17) is formed between the barrel space (15A) and the lure space (16A). The barrel space (15A) and the lure space (16A) are examples of internal spaces.

[0032] An annular portion (18) is formed at the tip of the tube portion (11). The annular portion (18) is positioned to surround the lure (16) from the tip of the barrel (15). An annular gap (14) is formed between the lure (16) and the annular portion (18). A flange (12) is formed on the outer surface of the base portion of the tube portion (11) and protrudes outward in the radial direction. The flange (12) functions as a finger grip for gripping the operator's fingers.

[0033] The attachment (30) is positioned to cover the opening on the tip side of the tube (11). The configuration of the attachment (30) will be described later.

[0034] The plunger (20) is a rod-shaped body that extends in a straight line. The plunger (20) is formed, for example, by glass or resin. The plunger (20) is inserted so as to be movable in the longitudinal direction of the barrel (11) within the barrel space (15A) of the tube (11). A gasket (22) is attached to the tip of the plunger (20). The gasket (22) is, for example, an elastic member, and is, for example, made of rubber. The outer diameter of the gasket (22) is approximately the same as the inner diameter of the barrel space (15A), and the outer surface of the gasket (22) is in close contact with the inner surface constituting the barrel space (15A) of the tube (11) over the entire circumference. Since the outer diameter of the gasket (22) is larger than the inner diameter of the lure space (16A), the gasket (22) (plunger (20)) is restricted from moving toward the tip side of the step (17).

[0035] A handle portion (24) and a flange (26) are formed on the base portion of the plunger (20). The flange (26) is formed to protrude outward in the radial direction from the outer surface of the base portion of the plunger (20). As shown in FIG. 2, the flange (26) is configured to come into contact with the flange (12) when the gasket (22) moves to a position where it touches the step (17) of the tube portion (11) or to a position immediately preceding therefrom. The handle portion (24) is a part that protrudes from the base portion of the plunger (20) toward the base side more than the flange (26). For example, as shown in FIGS. 1 and 2, when the gasket (22) is pushed into the front end of the barrel space (15A) of the tube (11), the operator can grasp the handle (24) with their fingers and pull the plunger (20) out of the barrel space (15A) of the tube (11).

[0036] (Detailed configuration of attachment (30) :

[0037] FIG. 3 is an explanatory diagram showing the side configuration of the attachment (30), FIG. 4 is an explanatory diagram showing the longitudinal configuration of the attachment (30), and FIG. 5 is an explanatory diagram showing the planar configuration of the attachment (30). FIG. 4 shows the cross-sectional configuration of the attachment (30) at position IV-IV of FIG. 3.

[0038] As shown in FIGS. 3 to 5, the attachment (30) is a cylindrical member overall. The attachment (30) is, for example, made of resin. The attachment (30) includes a mounting portion (31) and a receiving portion (33) located at the tip of the mounting portion (31). The mounting portion (31) and the receiving portion (33) are formed integrally, but may be separate. The mounting portion (31) is a portion that includes the base of the attachment (30). The mounting portion (31) is cylindrical in shape, and the inner diameter of the mounting portion (31) is larger than the outer diameter of the lure (16) of the tube portion (11), and the outer diameter of the mounting portion (31) is smaller than the inner diameter of the annular portion (18) (see FIG. 2). For this reason, the mounting portion (31) can be inserted into the gap (14) between the lure (16) and the annular portion (18). A male screw (35) is formed on the outer surface of the mounting portion (31) (see FIG. 3 and FIG. 4), and a female screw (not shown) that is screw-coupled with the male screw (35) is formed on the inner surface of the annular portion (18). By screw-coupled the male screw (35) of the mounting portion (31) to the female screw of the annular portion (18), the attachment (30) can be mounted on the tip of the tube (11). The attachment (30) may be detachable from the tube (11) or may not be detachable.

[0039] The receiving portion (33) is a portion that includes the tip of the attachment (30). The receiving portion (33) is cylindrical and has a through hole (34) formed that penetrates in the direction of the central axis of the attachment (30) (the longitudinal direction of the syringe (10)) (see FIG. 4). The base of the through hole (34) is connected to the space (32) on the inner side of the mounting portion (31), and the tip of the through hole (34) is opened to the tip surface (36) (an example of an outer surface) of the attachment (30).

[0040] The through hole (34) includes a first hole (34A), a second hole (34B), a third hole (34C), and a fourth hole (34D) (see FIG. 4).

[0041] The first hole (34A) is a concave portion that is radially opened toward the tip surface (36) of the attachment (30). The second hole (34B) is located on the base side of the first hole (34A). The base of the first hole (34A) is connected to the tip of the second hole (34B). The first area of ​​the cross-section of the first hole (34A) (the opening area of ​​the tip of the first hole (34A)) is larger than the second area of ​​the cross-section of the second hole (34B). The second area of ​​the second hole (34B) is smaller than the internal area of ​​the cross-section of the lure space (16A) of the tube (11). That is, the diameter of the second hole (34B) (e.g., diameter 1.5 mm or less) is smaller than the diameter of the first hole (34A) and also smaller than the diameter of the lure space (16A) (see FIG. 2).

[0042] The first hole (34A) is opened so that the cross-sectional area expands from the side of the second hole (34B) toward the side of the front face (36) of the attachment (30). That is, the shape of the first hole (34A) is a conical shape that opens radially toward the front face (36). The diameter of the second hole (34B) is almost the same over the entire length of the second hole (34B).

[0043] The third hole (34C) is located on the leading side of the first hole (34A). The base of the third hole (34C) is connected to the leading side of the first hole (34A). The diameter of the third hole (34C) is greater than the opening diameter of the leading side of the first hole (34A). The diameter of the third hole (34C) is nearly the same over the entire length of the third hole (34C). In short, the expansion rate of the third hole (34C) is smaller than the expansion rate of the first hole (34A). The expansion rate is the degree to which the opening area (diameter) of each hole expands toward the leading side (36). It is preferable that there is no step between the first hole (34A) and the third hole (34C).

[0044] The fourth hole (34D) is located between the third hole (34C) and the front end surface (36) of the attachment (30). The front end of the fourth hole (34D) is in contact with the front end surface (36), and the base end of the fourth hole (34D) is connected to the third hole (34C). The fourth hole (34D) is opened so that the cross-sectional area expands toward the front end surface (36). That is, the inner surface (40) constituting the fourth hole (34D) is a tapered surface that opens radially toward the front end surface (36). The fourth hole (34D) is located outside the first hole (34A) (third hole (34C)) when viewed in the axial direction of the attachment (30) (longitudinal direction of the syringe (10)), and is also positioned to surround the entire circumference of the first hole (34A) (third hole (34C)).

[0045] As shown in FIGS. 3 and 5, the attachment (30) has a plurality (e.g., four) of protrusions (42). Each protrusion (42) protrudes outward in the radial direction from the outer surface of the tip of the attachment (30). The plurality of protrusions (42) are arranged at equal intervals along the circumferential direction of the central axis of the attachment (30).

[0046] (Composition of Cartridge (200)):

[0047] FIG. 6 is a perspective view showing the external configuration of the cartridge (200).

[0048] The cartridge (200) is generally rectangular plate-shaped. The cartridge (200) has a base (210) and a cover (220). A rectangular receiving space (211) is formed on the upper surface of the base (210). The receiving space (211) is a space for receiving an immunochromatographic test specimen (not shown).

[0049] The cover (220) is a rectangular plate-shaped member and is preferably formed of a light-transmitting material (glass, resin, etc.), for example. The cover (220) is positioned to cover the receiving space (211) of the base (210). The cover (220) is positioned to cover the entire immunochromatographic test specimen received within the receiving space (211).

[0050] The cover (220) has a connecting portion (221). A connecting hole (224) is formed in the connecting portion (221). The connecting hole (224) is connected to a through hole (34) of the connected attachment (30) and is also connected to a receiving space (211) of the cartridge (200). The connecting hole (224) is positioned so as to be located directly above the sample pad of the immunochromatographic test specimen received in the receiving space (211).

[0051] The connecting part (221) has a plurality (e.g., 4) of engaging parts (226). Each engaging part (226) protrudes inward in the diametrical direction of the communication hole (224). The plurality of engaging parts (226) are arranged at equal intervals in the circumferential direction of the communication hole (224). Each protrusion (42) of the attachment (30) is inserted through the space between two adjacent engaging parts (226) to the inside of the communication hole (224) of the cover (220) (lower side in FIG. 6). Next, by rotating the attachment (30), each protrusion (42) moves downward of each engaging part (226). Accordingly, the attachment (30) is connected to the cover (220), and is prevented from coming off.

[0052] The connecting portion (221) has a contact portion (228). The contact portion (228) contacts the inner surface (40) of the attachment (30) connected to the connecting portion (221) over its entire circumference. The contact portion (228) is an annular portion that surrounds the entire circumference of the communication hole (224) and is formed as a tapered surface with a diameter that decreases toward the upper side (opposite side to the attachment (30)).

[0053] A camera window (222) is formed in the cover (220). The camera window (222) is positioned directly above the membrane (part showing the test line and control line) of the immunochromatographic test specimen housed in the housing space (211). The camera window (222) is thinner than other parts of the cover (220) and has high light transmittance. Because of this, each line appearing on the immunochromatographic test specimen can be clearly captured by an external camera.

[0054] A-2. How to use the blood collection kit (1):

[0055] (Blood collection (B) :

[0056] FIG. 7 is an explanatory diagram showing the change in state of the blood collection tube (100) during blood collection. First, the blood collection tube (100) is pushed into a pushed state. The pushed state is a state in which the plunger (20) is pushed into the barrel space (15A) so that the gasket (22) is positioned at the tip of the barrel space (15A) of the syringe (10). Next, the fingertip is punctured with, for example, a lancet (not shown) to induce bleeding. Next, as shown in the right drawing of FIG. 7, the attachment (30) of the blood collection tube (100) in the pushed state is turned upward, the bleeding fingertip is placed against the opening of the through hole (34) of the attachment (30), and blood (B) is dropped into the through hole (34). The diameter of the second hole (34B) is set to a size (e.g., 1 mm or more, 1.5 mm or less) such that the blood (B) does not pass through the second hole (34B) by its own weight due to surface tension, etc. Because of this, as shown in the center drawing of FIG. 7, the collected blood (B) accumulates in the first hole (34A) of the attachment (30). The volume of the first hole (34A) is an amount that can be normally tested by an immunochromatographic test specimen (e.g., 45 μl or more, 55 μl or less).

[0057] Next, when a buffer solution (C) is dropped onto the blood (B) accumulated in the first hole (34A) using a dropper (230), the dropped buffer solution (C) accumulates in the third hole (34C). The buffer solution (C) is intended to reduce the viscosity of the sample so that the sample passes over the membrane without clogging, and is a buffer solution (e.g., saline). Next, as shown in the left drawing of FIG. 7, a strong suction force is generated by pulling the plunger (20) away from the attachment (30) in a direction (downward direction of the ground in FIG. 7). Due to this suction force, the blood (B) in the first hole (34A) and the buffer (C) in the third hole (34C) pass through the second hole (34B) and move into the internal space (barrel space (15A) and Luer space (16A)) of the container (11), mixing with each other to form a mixture (M). Accordingly, the collection of blood (B) is completed. The volume of the first hole (34A) (through hole (34)) is larger than the volume of the barrel space (15A) of the container (11). Because of this, all of the mixture (M) in the through hole (34) can be drawn into the barrel space (15A).

[0058] (Dropping of blood (B) onto the immunochromatographic specimen) :

[0059] FIG. 8 is an explanatory diagram showing the process of connecting the blood collection tube (100) and the cartridge (200), and FIG. 9 is an explanatory diagram showing the state after the blood (B) is transferred from the blood collection tube (100) to the cartridge (200). As shown in the upper drawing of FIG. 8, the attachment (30) of the blood collection tube (100) after blood collection is placed downward and connected to the connection part (221) of the cartridge (200). At this time, the mixture (M) contained in the internal space of the tube (11) does not pass through the second hole (34B) due to its own weight. In short, the mixture (M) can be prevented from falling from the blood collection tube (100).

[0060] When the tip of the attachment (30) is inserted into the communication hole (224) of the connecting part (221) and the attachment (30) is rotated, the protrusion (42) of the attachment (30) and the engaging part (226) of the connecting part (221) are engaged, as shown in the lower drawing of FIG. 8. Accordingly, the blood collection port (100) is connected to the connecting part (221) (cartridge (200)) in a state where it is prevented from coming loose. At this time, the inner surface (40) of the attachment (30) and the contact part (228) of the connecting part (221) are in close contact over the entire circumference. Because of this, the through hole (34) of the attachment (30) and the communication hole (224) of the connecting part (221) are connected in a sealed state.

[0061] Next, as shown in FIG. 9, when the plunger (20) is pushed into the barrel space (15A), the mixture (M) passes through the second hole (34B) and is dropped onto the sample pad of the immunochromatographic test specimen through the connecting hole (224). By inserting the cartridge (200) containing the immunochromatographic test specimen on which the mixture (M) has been dropped into a known judgment device (not shown), an immunochromatographic test result can be obtained.

[0062] A-3. Effects of the present embodiment:

[0063] As explained above, in this embodiment, the first area of ​​the cross-section of the first hole (34A) is larger than the second area of ​​the cross-section of the second hole (34B) (see FIG. 4). Because of this, for example, compared to a configuration where the first area of ​​the first hole (34A) is less than or equal to the second area of ​​the second hole (34B), it is easier to place the sample (blood B) into the through hole (34) of the attachment (30). Conversely, because the second area of ​​the second hole (34B) is smaller than the first area of ​​the first hole (34A), it is difficult for the sample inside the first hole (34A) to move into the internal space (barrel space (15A)) of the syringe (10), and it is also easy to determine the amount of sample collected in the first hole (34A).

[0064] After placing the sample into the through hole (34), the sample in the first hole (34A) is sucked into the internal space (barrel space (15A)) of the syringe (10) through the second hole (34B) by the suction force generated by pulling the plunger (20) away from the attachment (30). Since the second area of ​​the second hole (34B) is smaller than the area of ​​the internal space (barrel space (15A)) (see FIG. 2), the sample that has moved into the internal space can be prevented from flowing back into the first hole (34A).

[0065] As such, according to the present embodiment, it is possible to facilitate sample collection, determine the amount of sample collected, and suppress leakage of the collected sample.

[0066] In this embodiment, the first hole (34A) is opened so that the cross-sectional area expands from the side of the second hole (34B) toward the side of the front face (36) of the attachment (30) (see FIG. 4). Accordingly, compared to a configuration where, for example, the cross-sectional area of ​​the first hole (34A) is constant, it is easier to insert a sample into the through hole (34) (the first hole (34A)).

[0067] The third hole (34C) is located on the leading side of the first hole (34A), thereby securing a space for receiving the buffer solution (C). The expansion rate of the third hole (34C) is different from the expansion rate of the first hole (34A). For this reason, the boundary between the two is easily visible by marking the displacement positions of the expansion rates of the first hole (34A) and the third hole (34C). Since the expansion rate of the third hole (34C) is smaller than the expansion rate of the first hole (34A), it is easy to determine whether there is any buffer solution (C) dropped into the third hole (34C).

[0068] B. Second embodiment:

[0069] B-1. Configuration of Information Management System (1A):

[0070] FIG. 10 is an explanatory diagram showing the configuration of an information management system (1A) in the present embodiment. The information management system (1A) comprises a plurality of terminal devices (11A) (first terminal device (11A1), second terminal device (11A2)) each of a plurality of medical institutions (10A) (first medical institution (10A1), second medical institution (10A2)), a terminal device (51) owned by a public institution (50), a management server (400), and a plurality of user terminal devices (500). Each device or system is connected to each other through a network (NW). The medical institutions (10A) are facilities such as, for example, hospitals, clinics, visiting nursing stations, nursing support offices, nursing service offices, etc. The public institutions (50) are facilities such as, for example, social welfare corporations, medical corporations, public health centers, and government offices of cities, towns, and villages. Although two medical institutions (10A) are shown in FIG. 10, the number of medical institutions (10A) included in the information management system (1A) may be one or three or more. Likewise, although two user terminal devices (500) are shown in FIG. 10, the number of user terminal devices (500) included in the information management system (1A) may be one or three or more. Although one public institution (50) is shown in FIG. 10, the number of public institutions (50) included in the information management system (1A) may be two or more. A user terminal device (500) is an example of an information processing device.

[0071] A terminal device (11A) owned by a medical institution (10A) is a computer that supports the work of each doctor or each employee, etc., by enabling the recording of medical information, such as examination results or test results, written by each doctor or each employee affiliated with the medical institution (10A), or by making it possible to view such information when necessary. For example, a personal computer, a tablet terminal, a smartphone, etc., are used as the terminal device (11A).

[0072] The terminal device (11A) is equipped with a control unit (120), a memory unit (130), and a communication unit (140). The memory unit (130) is configured, for example, by a hard disk drive (hereinafter referred to as "HDD"), ROM, RAM, or a cloud with guaranteed protection against leakage of confidential information, and stores various data such as medical information of a user (patient, etc.) or various programs for controlling the terminal device (11A). The communication unit (140) is an interface that performs communication with an external device by means of a wireless communication method or a wired communication method. The control unit (120) is configured, for example, by a central control unit (hereinafter referred to as "CPU"), and controls each part of the terminal device (11A) according to a program read from the memory unit (130).

[0073] A terminal device (51) owned by a public institution (50) is a computer that supports the work of each doctor or each employee, etc., by enabling the recording of medical information, such as examination results or test results, written by each employee, etc., affiliated with the public institution (50), or by making it possible to view such information when necessary. For example, a personal computer, a tablet terminal, a smartphone, etc., are used as the terminal device (51).

[0074] The terminal device (51) is equipped with a control unit (52), a memory unit (54), and a communication unit (56). The memory unit (54) is configured, for example, by a hard disk drive (hereinafter referred to as "HDD"), ROM, RAM, or a cloud with guaranteed protection against leakage of confidential information, and stores various data such as user's medical information or various programs for controlling the terminal device (51). The communication unit (56) is an interface that performs communication with an external device by means of a wireless communication method or a wired communication method. The control unit (120) is configured, for example, by a CPU, and controls each part of the terminal device (51) according to a program read from the memory unit (54).

[0075] The management server (400) is a device that manages information regarding a user's personal information or the diagnosis results of an infection transmitted from each user terminal device (500). The management server (400) is equipped with a control unit (420), a memory unit (430), a communication unit (440), an operation unit (450), and a display unit (460). The memory unit (430) is configured, for example, by an HDD, ROM, RAM, or a cloud that guarantees the prevention of leakage of confidential information, and stores various data such as a user's medical information or various programs for controlling the management server (400). The communication unit (440) is an interface that performs communication with an external device by means of a wireless communication method or a wired communication method. The operation unit (450) is configured, for example, by a keyboard or mouse, and receives operations from an administrator. The display unit (460) is configured, for example, by a liquid crystal display. The control unit (420) is configured by, for example, a CPU, and controls each part of the management server (400) according to a program read from the memory unit (430).

[0076] The user terminal device (500) is a device used by the user, such as a personal computer, a tablet terminal, or a smartphone. The user terminal device (500) is placed, for example, at the user's home, the user's workplace, each medical institution (10A), or a public institution (50). The user terminal device (500) is equipped with a control unit (520), a memory unit (530), a communication unit (540), an operation unit (550), and a display unit (560). The memory unit (530) is composed of, for example, an HDD, ROM, RAM, or a cloud that guarantees the prevention of leakage of confidential information, and stores various data or various programs for controlling the user terminal device (500) (including an infection determination processing program described later). The communication unit (540) is an interface that performs communication with an external device by means of a wireless communication method or a wired communication method. In this embodiment, a reader (300) is connected to a user terminal device (500) so as to be able to communicate through a communication unit (540). An operation unit (550) is configured, for example, by a keyboard or mouse, and receives user operations. A display unit (560) is configured, for example, by a liquid crystal display (see FIG. 20 described later). A control unit (520) is configured, for example, by a CPU, and controls each part of the user terminal device (500) according to a program read from a memory unit (530). The control unit (520) is an example of a controller, and the display unit (560) is an example of a notification unit.

[0077] B-2. Composition of Cartridge and Reader :

[0078] FIG. 11 is a top view showing the external configuration of a cartridge (200A) and a reader (300), and FIG. 12 is a cross-sectional view showing the internal configuration of a cartridge (200A) and a reader (300). FIG. 12 shows the cross-sectional configuration of the cartridge (200A) and the reader (300) at position XII-XII of FIG. 11. The cartridge (200A) accommodates an immunochromatographic test specimen (P) (see FIG. 19 described later). The reader (300) captures each line appearing on the immunochromatographic test specimen (P) accommodated in the cartridge (200A) (see FIG. 19 described later), generates image data of the lines, and transmits it to a user terminal device (500).

[0079] As shown in FIGS. 11 and 12, the reader (300) has a casing body (311), a camera (313), a control board (314), a battery (315), a communication port (316), a first indicator light (312a), and a second indicator light (312b). The casing body (311) is formed of, for example, a resin material, bioplastic, or metal.

[0080] The casing body (311) is a rectangular box body overall. Inside the casing body (311), a cartridge receiving space (318) and a device receiving space (S1) are provided. The cartridge receiving space (318) is a space that extends in a straight line along the longitudinal direction of the casing body (311). An insertion opening (318A) is formed on one end surface (the surface on the Y-axis forward side) in the longitudinal direction of the casing body (311). The cartridge receiving space (318) is connected to the insertion opening (318A). A cartridge (200A) is received in the cartridge receiving space (318) through the insertion opening (318A). Inside the casing body (311), a passage (317) is formed that connects the cartridge receiving space (318) and the device receiving space (S1). The passageway (317) is a path that penetrates in the vertical direction (Z-axis direction). The passageway (317) is positioned so that the camera window (222A), described later, of the cartridge (200A) received in the cartridge receiving space (318) is located directly below the passageway (317).

[0081] In the device receiving space (S1), a camera (313), a control board (314), and a battery (315) are received. The camera (313) is positioned above the communication channel (317). The camera (313) captures an image directly below the communication channel (317) and outputs image data corresponding to the captured image. The camera (313) is positioned so that it can capture the camera window (222A) (membrane of the immunochromatographic test specimen (P)) of the cartridge (200A) received in the normal reference position of the cartridge receiving space (318) through the communication channel (317). The battery (315) supplies power to the camera (313) and the control board (314). Additionally, the reader (300) may be configured to be powered by an external power source (e.g., user terminal device (500)) without having a battery (315). The communication port (316) is connected to the user terminal device (500) via a wired connection, such as a USB (Universal Serial Bus) cable. Additionally, the reader (300) may be configured to be connected to the user terminal device (500) via wireless communication.

[0082] The control board (314) controls each device of the reader (300). The first indicator light (312a) and the second indicator light (312b) are placed on the outer surface (upper surface) of the casing body (311). The first indicator light (312a) and the second indicator light (312b) light up in various lighting patterns according to the results of determining the operating state or infection state of the reader (300). Specifically, the control board (314) controls the light-emitting operation of the first indicator light (312a) and the second indicator light (312b) in a plurality of light-emitting patterns that can be identified from each other according to at least two of the following results (a) to (d), for example.

[0083] (a) Determination result regarding the placement position of the cartridge (200A):

[0084] The determination result regarding the placement position is the determination result of whether the cartridge (200A) is placed in the reference position (a position where the camera (313) can normally photograph the membrane of the immunochromatographic test specimen (P) contained in the cartridge (200A)) within the cartridge receiving space (318). The control board (314) determines that the cartridge (200A) is placed in the reference position, for example, based on image data output by the camera (313), on the condition that the control part (Pc) or the test part (Pt) is detected in the captured image.

[0085] (b) Judgment result regarding the immunochromatographic specimen (P) contained in the cartridge (200A):

[0086] The judgment result regarding the immunochromatographic test specimen (P) is the judgment result of whether the immunochromatographic test specimen (P) contained in the cartridge (200A) matches the inspection item specified by the user. The control board (314) detects the inspection item targeted by the immunochromatographic test specimen (P) currently contained in the cartridge (200A) based on image data output by, for example, the camera (313). The control board (314) detects the type of inspection item based on an identification code (e.g., barcode, etc.) displayed on the immunochromatographic test specimen (P) or the color of a specific point (conjugate pad, etc.) of the immunochromatographic test specimen (P). The control board (314) determines that a normal immunochromatographic test specimen (P) is contained in the cartridge (200A) under the condition that the detected test item matches the type of test item specified by the user terminal device (500).

[0087] (c) Result of determination regarding the normal conduct of the examination using the immunochromatographic specimen (P):

[0088] The result of the determination regarding the normal execution of the inspection is the result of determining whether the inspection by the immunochromatographic test specimen (P) was performed normally. The control board (314) determines that the inspection by the immunochromatographic test specimen (P) was performed normally, for example, based on image data output by the camera (313), on the condition that a control line on the immunochromatographic test specimen (P) is detected.

[0089] (d) Assessment result regarding infection status:

[0090] The result of the determination regarding the infection status is the result of determining whether the test result for the test item is positive or negative. The control board (314) determines that it is positive based on the condition that both the control line and the test line on the immunochromatographic test piece (P) are detected based on image data output by the camera (313), determines that it is negative if the control line is detected but the test line is not detected, and determines that it is impossible to determine if the control line is not detected.

[0091] In addition, the judgment notification unit for notifying the external judgment results of (a) to (d) above is not limited to a light-emitting device that emits light in a plurality of light-emitting patterns that can be identified from one another according to the judgment results, and may be a display device that displays characters, etc. according to the judgment results, a pronunciation device that emits voice according to the judgment results, or a transmission device that transmits judgment result data according to the judgment results to an external device (500, etc.).

[0092] The cartridge (200A) includes a cartridge body (202A) and a cartridge cap (230A). FIG. 13 is a top view showing the configuration of the cartridge body (202A). FIG. 14 is a perspective view showing the configuration of the cartridge cap (230A) (excluding the cap sheet (231) described later), and FIG. 15 is a side view showing the configuration of the cartridge cap (230A). FIG. 16 is a cross-sectional view showing an enlarged view of the front portion (H) of the cartridge in FIG. 12.

[0093] As shown in FIG. 13, the cartridge body (202A) is generally rectangular plate-shaped. The cartridge body (202A) is equipped with a base (210A) and a cover (220A). A rectangular receiving space (S2) is formed on the upper surface of the base (210A). The receiving space (S2) is a space for receiving an immunochromatographic test specimen (P).

[0094] The cover (220A) is a rectangular plate-shaped member and is preferably formed of, for example, a light-transmitting material (glass, resin, etc.). The cover (220A) is positioned to cover the receiving space (S2) of the base (210A). The cover (220A) is positioned to cover the entire immunochromatographic test specimen (P) received within the receiving space (S2).

[0095] The cover (220A) is provided with a connecting portion (221A). A communication hole (224A) is formed in the connecting portion (221A). The communication hole (224A) communicates with the receiving space (S2) of the cartridge body (202A). The communication hole (224A) is a hole that penetrates the cover (220A) in a direction perpendicular to the base (210A) (up and down direction), and the communication hole (224A) is positioned so as to be located directly above the sample pad of the immunochromatographic test specimen (P) received in the receiving space (S2). The communication hole (224A) includes a first communication hole (224B), a second communication hole (224C), and a third communication hole (224D). The first communication hole (224B) is a hole that opens on the opposite side of the receiving space (S2) (base (210A)) in the connection part (221A). The first communication hole (224B) is a cylindrical hole with a diameter that is nearly the same along the entire length along the central axis (up and down direction) of the communication hole (224A). The second communication hole (224C) is located directly below the first communication hole (224B) and is a conical hole with a diameter that decreases as it approaches the base (210A). The third communication hole (224D) is located directly below the second communication hole (224C) and is a hole with a diameter that is nearly the same as the minimum diameter of the second communication hole (224C). The connecting part (221A) is an example of a receiving part, the second connecting hole (224C) is an example of a first hole, the third connecting hole (224D) is an example of a second hole, and the first connecting hole (224B) is an example of a third hole.

[0096] Additionally, a notch (210C) is formed on one end of the base (210A). A protrusion (222B) is formed on one end of the cover (220A). The protrusion (222B) is shaped to be insertable into the notch (210C). For this reason, for example, the cover (220A) is prevented from being positioned in the opposite direction relative to the base (210A). The shapes of the two corner portions of the tip portion inserted into the cartridge receiving space (318) of the cartridge body (202A) (base (210A)) are different from each other. Specifically, the shape of the corner portion on one side (X-axis forward direction side) is angular, and the shape of the corner portion (210B) on the other side (X-axis negative direction side) is cut flat. The inner wall surface forming the cartridge receiving space (318) in the casing body (311) is shaped to correspond to the shape of each corner portion. For this reason, for example, if the cartridge body (202A) is inserted into the cartridge receiving space (318) in a direction inverted in the up and down direction, the cartridge body (202A) cannot reach the reference position.

[0097] As shown in FIGS. 14 and 15, the cartridge cap (230A) comprises a cap sheet (231), a plate portion (233), and a leg portion (238). The cartridge cap (230A) is formed from a resin material, a bioplastic or rubber material, etc. It is preferable that the cartridge cap (230A) be formed from an elastic material. The leg portion (238) is an example of a press-fit portion.

[0098] The plate portion (233) is approximately flat and has a protruding portion (233A) that protrudes in one direction (Y-axis forward). On the upper surface of the plate portion (233), a receiving hole (232) for receiving a buffer solution (C) is formed. The receiving hole (232) includes a first receiving hole (234) and a second receiving hole (236). The first receiving hole (234) faces the bottom surface (234A) of the receiving hole (232). The first receiving hole (234) is a hole partitioned by a radial inner circumference (234B) whose diameter increases as it moves away from the bottom surface (234A). The first receiving hole (234) has a first protruding hole (234D) that protrudes toward the protruding portion (233A). The first protruding hole (234D) has a shape that narrows in width as it faces the tip in the direction of the protrusion.

[0099] The second receiving hole (236) is located directly above the first receiving hole (234) and is connected to the first receiving hole (234). The second receiving hole (236) is a hole partitioned by a radial inner surface (236B) whose diameter increases as it moves away from the bottom surface (234A). Also, the angle of inclination of the inner surface (236B) relative to the bottom surface (234A) is gentler than the angle of inclination of the inner surface (234B) relative to the bottom surface (234A). The second receiving hole (236) has a second protruding hole (236D) that protrudes in the aforementioned direction (Y-axis forward direction). The second protruding hole (236D) has a shape in which the width narrows as it faces the tip of the protruding direction. Also, the protrusion angle (the angle between the two sides forming the protrusion) of the second protruding hole (236D) is smaller than the protrusion angle of the first protruding hole (234D).

[0100] The leg portion (238) protrudes downward from the lower surface of the plate portion (233). The leg portion (238) is approximately cylindrical. On the outer surface of the leg portion (238), a convex portion (238A) protruding outward in the radial direction is formed along the entire circumference. When the leg portion (238) is inserted into the communication hole (224A), the convex portion (238A) is compressed and deformed, thereby sealing the inside of the communication hole (224A). The front end surface (238B) of the leg portion (238) is a tapered surface whose diameter decreases as it moves away from the plate portion (233). The angle of inclination of the front end surface (238B) relative to the base (210A) is approximately the same as the angle of inclination of the second communication hole (224C) relative to the base (210A).

[0101] The cover (220A) is provided with a pair of pressing parts (224E, 224E) (see FIG. 16). Each pressing part (224E) is formed to protrude downward from the surface (bottom) of the cover (220A) facing the base (210A). The pair of pressing parts (224E, 224E) are positioned to interpose the third communication hole (224D) in the longitudinal direction (Y-axis direction) of the cartridge body (202A) (immunochromatic test specimen (P)) when viewed from the central axis direction (Z-axis direction) of the communication hole (224A). A pair of pressing parts (224E, 224E) are located directly below the third communication hole (224D) in the receiving space (S2) to secure a gap between the lower surface of the cover (220A) and the immunochromatographic test specimen (P) while suppressing the lifting of the immunochromatographic test specimen (P). Additionally, the pair of pressing parts (224E, 224E) are positioned to interpose the third communication hole (224D) in the width direction (X-axis direction) of the cartridge body (202A) (immunochromatographic test specimen (P)).

[0102] The cover (220A) is provided with a pair of pressure portions (224F, 224F) (see FIG. 13). Each pressure portion (224F) is formed to protrude downward from the surface (bottom) of the cover (220A) facing the base (210A). The pair of pressure portions (224F, 224F) are positioned to interpose the third communication hole (224D) in the width direction (X-axis direction) of the cartridge body (202A) (immunochromatic test specimen (P)) when viewed from the center axis direction (Z-axis direction) of the communication hole (224A). A pair of pressurizing parts (224F, 224F) are located directly below the third communication hole (224D) in the receiving space (S2) and pressurize both sides of the immunochromatographic test specimen (P) in the width direction while securing a gap between the lower surface of the cover (220A) and the immunochromatographic test specimen (P). Accordingly, blood (B) dropped from the third communication hole (224D) is prevented from escaping from the immunochromatographic test specimen (P) and can be guided to the membrane.

[0103] The cap sheet (231) is a sheet material and seals the receiving hole (232) of the cartridge cap (230A). The cap sheet (231) has the same external shape as the plate portion (233) of the cartridge cap (230A). The peripheral portion of the cap sheet (231) and the portion surrounding the receiving hole (232) of the plate portion (233) are peelably bonded together. Accordingly, the buffer liquid (C) is received in a sealed state within the receiving hole (232) (see FIG. 16). The cap sheet (231) is, for example, an aluminum sheet.

[0104] B-3. ​​How to use the cartridge (200A):

[0105] FIG. 17 is an explanatory diagram showing the process of using a cartridge (200A). First, the user separates the leg portion (238) of the cartridge cap (230A) from the communication hole (224A) of the cartridge body (202A) and opens the communication hole (224A) (see FIG. 16). Next, the user punctures the fingertip, for example, with a lancet (not shown), to induce bleeding. Next, as shown in the upper drawing of FIG. 17, the user positions the cartridge body (202A) so that the communication hole (224A) opens upward, places the bleeding fingertip against the opening of the communication hole (224A), and drops blood (B) into the communication hole (224A). The diameter of the third connecting hole (224D) is set to a size (e.g., 1 mm or more, 1.5 mm or less) such that the blood (B) does not pass through the third connecting hole (224D) by its own weight due to surface tension, etc. Because of this, as shown in the central drawing of FIG. 17, the collected blood (B) accumulates in the second connecting hole (224C). The capacity of the second connecting hole (224C) is an amount that can be normally tested by an immunochromatographic test specimen (e.g., 45 μl or more, 55 μl or less).

[0106] Next, the user removes the cap sheet (231) from the plate portion (233) and drops the buffer solution (C) contained in the receiving hole (232) of the plate portion (233) onto the blood (B) accumulated in the second communication hole (224C). At this time, the user places the tip of the plate portion (233) directly over the opening of the communication hole (224A) and tilts the plate portion (233) so that the leg portion (238) side moves upward. Accordingly, the buffer solution (C) is smoothly dropped from the receiving hole (232) through the first protruding hole (234D) and the second protruding hole (236D) into the communication hole (224A). The dropped buffer solution (C) accumulates in the first communication hole (224B). Next, as shown in the lower drawing of FIG. 17, the user pushes the leg portion (238) of the plate portion (233) into the communication hole (224A). Then, the blood (B) in the second communication hole (224C) and the buffer solution (C) in the first communication hole (224B) mix together and pass through the third communication hole (224D) to become a mixture (M), which is then applied onto the sample pad of the immunochromatographic test specimen (P).

[0107] B-4. Infection Determination Processing :

[0108] FIG. 18 is a flowchart illustrating an infection determination process. A user connects a reader (300) to a user terminal device (500) so as to be communicable, and inserts a cartridge (200A) containing an immunochromatographic test specimen (P) from which blood collection has been completed into the insertion port (318A) of the reader (300). Next, the user performs a predetermined operation by means of the operation unit (550) of the user terminal device (500), and the control unit (520) reads an infection determination process program from the memory unit (530) and executes the infection determination process shown in FIG. 18. The infection determination process is a process for determining the user's infection status based on image data (hereinafter referred to as "membrane image data") generated by the reader (300) capturing the membrane of the immunochromatographic test specimen (P).

[0109] As shown in FIG. 18, the control unit (520) acquires sample data (membrane image data) (S110). Specifically, the control unit (520) transmits a shooting instruction to the reader (300). The control board (314) of the reader (300) controls the camera (313) based on the shooting instruction received from the user terminal device (500) to photograph the portion containing the membrane of the immunochromatographic test specimen (P) contained in the cartridge (200A) and generate membrane image data. The control board (314) transmits the generated membrane image data to the user terminal device (500) through the communication port (316). The control unit (520) acquires the membrane image data through the communication unit (540). The communication unit (540) is an example of an acquisition unit, the processing of S110 is an example of an acquisition processing and acquisition process, and the membrane image data is an example of collection information based on the user's sample collection result.

[0110] The control unit (520) does not transmit the membrane image data acquired from the reader (300) to the management server (400). The control unit (520) executes a determination process to determine the user's infection status based on the acquired membrane image data. This will be explained in detail below. In this embodiment, the infection status includes a reference value indicating the presence or absence of infection (antigen or antibody) in the test item and the level of infection (amount of antigen or antibody).

[0111] The control unit (520) performs image conversion processing on the acquired membrane image data (S120). Specifically, the control unit (520) first converts the membrane image data (e.g., color image data or grayscale image data) into binarized image data. Next, the control unit (520) divides the binarized image data into units of predetermined scan frames (F), detects the presence or absence of lines based on the number of dots within each scan frame (F), and determines the infection state based on the result of detecting the presence or absence of lines (S130). S130 is an example of a determination processing and a determination process.

[0112] FIG. 19 is an explanatory diagram showing the detection process for the presence or absence of lines in an immunochromatographic test specimen (P). FIG. 19 shows a membrane image (E) captured by a camera (313) of a reader (300). The membrane image (E) includes a control portion (Pc) and a test portion (Pt) of the immunochromatographic test specimen (P). The control portion (Pc) is the portion where the control line (C) appears, and the test portion (Pt) is the portion where the test line (T) appears. The control unit (520) performs frame detection processing targeting each of the control area (Gc) containing the control portion (Pc) and the test area (Gt) containing the test portion (Pt) in the membrane image (E).

[0113] Frame detection processing is a process of sequentially moving a predetermined scan frame (F) within a target area along the length direction of P and detecting the presence or absence of a line based on the number of dots within the scan frame (F) at each scan position within the target area. In this embodiment, the control area (Gc) and the test area (Gt) are both rectangular. The width of the scan frame (F) (length in the width direction of the immunochromatographic test specimen (P)) is approximately the same as the width of each target area (control area (Gc), test area (Gt)). The height of the scan frame (F) (length in the length direction of the immunochromatographic test specimen (P)) is shorter than the height of each target area (e.g., 1 / 5 or less). The scan frame (F) moves along the length direction of the immunochromatographic test specimen (P) to pass through each of the control area (Gc) and the test area (Gt). In addition, in the frame detection process, the control unit (520) may count the number of dots for the entire membrane image (E) and detect the presence or absence of a line based on the number of dots. However, as in the present embodiment, if the presence or absence of a line is detected by targeting a partial area (control area (Gc), test area (Gt)) that includes each part (control part (Pc), test part (Pt)) of the immunochromatographic test specimen (P) in the captured image (membrane image (E)), the line detection accuracy is improved. Furthermore, as in the present embodiment, if a scan frame (F) with a vertical width shorter than that of the target area is used for each target area and the presence or absence of a line is detected based on the number of dots in the scan frame (F) at each scan position, the line detection accuracy is further improved.

[0114] The control unit (520) counts the number of dots detected at each scan position within each target area (hereinafter referred to as "dot detection count") and determines that there is a line at the scan position based on the condition that the dot detection count is greater than or equal to a reference value. The control unit (520) determines the infection state as follows based on the line detection result.

[0115] (a) Voice: When the control unit (520) determines that there is a line in the control area (Gc) and determines that there is no line in the test area (Gt)

[0116] (b) Positive: When the control unit (520) determines that there is a line in the control area (Gc) and determines that there is a line in the test area (Gt)

[0117] (c) Inspection error: When the control unit (520) determines that there is no line in the control area (Gc)

[0118] The control unit (520) notifies the judgment result (S140). Specifically, the control unit (520) transmits the judgment result to the reader (300) through the communication unit (540). The control board (314) of the reader (300) emits the first indicator light (312a) and the second indicator light (312b) according to the received judgment result. Accordingly, the user can see the light emission pattern of the light-emitting device (first indicator light (312a), second indicator light (312b)) of the reader (300) and determine their infection status (whether or not they are infected with a disease, etc., which is a test item). The control unit (520) displays the infection result on the display unit (560). Accordingly, the user can see the display content of the display unit (560) of the user terminal device (500) and determine their infection status. S140 is an example of a notification processing and notification process.

[0119] FIG. 20 is an explanatory diagram showing a screen display of a display unit (560) of a user terminal device (500). When the control unit (520) determines that the judgment result is positive (S150: Yes), it displays the positive judgment result screen of FIG. 20 (A) on the display unit (560). The positive judgment result screen includes a judgment result column (562), a start level selection column (564), and a feedback column (565).

[0120] The judgment result column (562) is a column that displays the judgment result of the infection status. If the judgment result is positive (S150: e.g.), the judgment result column (562) displays an indication of "positive" and an indication urging the patient to go to a hospital to receive a medical examination (e.g., "examination required"). The judgment result column (562) additionally displays the above reference value. The reference value is an approximate amount of antigen or antibody of the test item. The control unit (520) calculates the total number of dots detected within the test area (Gt) in the above line detection process (or the total number of dots detected within the scan frame (F) at the scan position where the line was detected), determines a reference value corresponding to the total number of dots, and displays the determined reference value in the judgment result column (562).

[0121] The control unit (520) receives permission information that permits the commencement of the infection status determination result or selection information that selects a target for commencement from among multiple types of user-related information through the commencement level selection column (564) (S160). The processing of S160 is an example of permission reception processing (permission reception process) and selection reception processing (selection reception process).

[0122] Specifically, the initiation level selection field (564) is a field that allows the user to select the initiation level of user-related information regarding the judgment result or the user. User-related information includes, for example, attribute information and infection factor information. Attribute information is information regarding the user's attributes, and the types of attribute information include, for example, personal information such as information regarding the user's body (gender, age, infection history, occupation, symptoms, disease), and location information of the user (location of home or workplace (GPS)). Infection factor information is information regarding the factor in which the user was infected, and the types of infection factor information include, for example, the estimated time of infection, the estimated place of infection, and the estimated behavior of infection. Examples of options displayed in the initiation level selection field (564) are as follows.

[0123] (a) Whether permission to commence the judgment result is granted

[0124] (b) Whether permission to disclose attribute information is granted (may include whether permission to disclose is granted for each of the multiple types of attribute information above)

[0125] (c) Whether permission to disclose infection factor information is granted (may include whether permission to disclose is granted for each of the above multiple types of infection factor information)

[0126] The user operates the control unit (550) to select any option from among the multiple options displayed in the start level selection box (564). The control unit (520) receives the permission information and selection information based on the result of the user's selection. Additionally, the control unit (520) may display options (b) and (c) in the start level selection box (564), provided that the start permission of the judgment result in (a) is selected as a necessary condition.

[0127] The control unit (520) transmits judgment information or user-related information corresponding to the option selected in the start level selection box (564) to the management server (400) (S170). Specifically, if the user selects no permission to start the judgment result, the control unit (520) does not transmit the judgment information to the management server (400). Accordingly, the user can go to the hospital and receive a medical examination while ensuring the confidentiality of the judgment result from the user terminal device (500).

[0128] The control unit (520) transmits judgment information regarding a positive judgment result to the management server (400) when the user selects permission to initiate the judgment result. This process is an example of a transmission process (transmission process). Additionally, the control unit (520) may transmit the membrane image data (which may be data before binarization or data after binarization) to the management server (400) when the user selects permission to initiate the judgment result. Based on the received membrane image data, the management server (400) may execute a judgment process for an infection state that has a higher judgment accuracy than the infection judgment process at the user terminal device (500) and transmit the judgment result to the user terminal device (500). The user terminal device (500) may display the judgment result by the management server (400) on, for example, a display unit (560). Accordingly, the user can obtain a high-precision judgment result (online) by the management server (400) in addition to the judgment result by the user terminal device (500) by the simple judgment (offline).

[0129] The control unit (520) transmits user-related information of the type selected in the start level selection field (564) to the management server (400). The control unit (520) transmits user-related information to the management server (400) in addition to the judgment information, provided that the user has selected permission to start the judgment result as a necessary condition. Additionally, the control unit (520) may transmit user-related information to the management server (400) regardless of whether the user has permission to start the judgment result.

[0130] The control unit (520) displays feedback information corresponding to the type of user-related information selected in the start level selection box (564) (if multiple types of user-related information are selected, a combination pattern of multiple types of user-related information) in the feedback box (565) (S180), and terminates the infection determination process. The feedback information is, for example, as follows.

[0131] (a) Where user's physical information is selected: Advice from a medical professional (doctor, etc.) based on physical information (e.g., methods of response or precautions based on age, gender or history of infection, information on infected diseases, etc.) or contact information of a specialist (telephone number, email address, etc.)

[0132] (b) If user location information is selected: hospital information of specialists for the infected disease (e.g., information on hospitals where consultation is available based on the user's location (information on hospitals near the user's location, etc.))

[0133] (c) If infection factor information is selected: Advice by healthcare professionals based on the infection factor (e.g., coping methods or precautions based on the elapsed time since the estimated time of infection)

[0134] (d) Information regarding communication with healthcare professionals (healthcare personnel) (e.g., options for multiple types of communication means, such as online communication with healthcare professionals, face-to-face communication with healthcare professionals, email communication with healthcare professionals, telephone communication with healthcare professionals, etc., and information regarding each communication means (e.g., how to use, contact information, etc.))

[0135] Also, the feedback information may be information that is stored in advance in the memory unit (530) of the user terminal device (500) and provided offline, or information that is provided online from the management server (400).

[0136] When the judgment result is negative (S150: No), the control unit (520) displays the negative judgment result screen of FIG. 20(B) on the display unit (560). The negative judgment result screen includes the judgment result column (562), the estimated time of infection column (566), and the feedback column (565). When the judgment result is negative (S150: No), the judgment result column (562) displays an indication that it is "negative" and the reference value.

[0137] The estimated time of infection (566) is a field where the user inputs the estimated time of infection (e.g., year, month, day, or time). The estimated time of infection is, for example, the time when the user performed an act that could be a cause of infection, or the time when symptoms (such as fever) due to infection occurred. The control unit (520) determines whether the estimated time of infection has been entered into the estimated time of infection field (566) (S190). The processing of S190 is an example of processing the time receipt. If the control unit (520) determines that the estimated time of infection has been entered (S190: yes), it determines whether the result of determining the infection status is valid based on the estimated time of infection (S200). For example, the control unit (520) determines that if the period from the time of estimated infection to the date of execution of infection determination processing by the user terminal device (500) (hereinafter referred to as the “infection elapsed period”) is within the appropriate testing period for the test item (e.g., influenza) (e.g., after 12 hours have passed since onset), the infection status determination result (negative) is valid, and if the infection elapsed period is outside the appropriate testing period (e.g., before 12 hours have passed since onset), the infection status determination result (negative) is invalid.

[0138] The control unit (520) displays feedback information based on the result of the judgment of appropriateness on the display unit (560) (S210) and terminates the infection judgment process. For example, if the control unit (520) determines that the result of the judgment of the infection state (negative) is valid, it displays a notice in the feedback column (565) indicating that the result of the judgment of the infection state (negative) is valid. If the control unit (520) determines that the result of the judgment of the infection state (negative) is invalid, it displays information regarding the appropriate time for testing (e.g., the time when the appropriate testing period has elapsed since the onset of the infection) in the feedback column (565). Additionally, an alarm setting may be displayed in the feedback column (565). The alarm setting is a setting to notify the user of the fact when the time elapsed since the infection has elapsed is within the appropriate testing period (e.g., an alarm is displayed on the display unit (560)). The user can enable the alarm function by setting the alarm setting to "ON".

[0139] The control unit (520) may, before processing the infection determination, determine the inspection item of the immunochromatographic test specimen (P) received in the reader (300) based on the captured image data from the reader (300) (identification information of the inspection item displayed on the immunochromatographic test specimen (P)), and determine whether the specified inspection item matches the inspection item specified by the user in the operation unit (550). Information regarding the inspection item specified by the user may be displayed on the display unit (560) (such as the judgment result display screen of FIG. 20).

[0140] The management server (400) may transmit the judgment information or user-related information received from each user terminal device (500) to the terminal device (11A) of each medical institution (10A) or the terminal device (51) of the public institution (50). Each medical institution (10A) may, for example, use the received judgment information or user-related information for the examination of a visiting user. The public institution (50) may, for example, manage the received judgment information or user-related information as big data and use it for identifying infected areas or predicting infections based on the big data.

[0141] C. Variant Example :

[0142] The technology disclosed in this specification is not limited to the embodiments described above and can be modified in various forms without departing from the gist thereof, and, for example, the following modifications are possible.

[0143] The configuration of the blood collection kit (1), blood collection tube (100), and reader (300) in the first embodiment above is merely an example and can be modified in various ways. For example, in the first embodiment above, the tube (11) and the attachment (30) were joined by screw connection, but they may be joined by, for example, press-fitting or adhesive. In the first embodiment above, the attachment (30) which is separate from the tube (11) was exemplified as the receiving part, but the receiving part may be formed integrally with the tube (11).

[0144] In the first embodiment above, the through hole (34) of the attachment (30) was extended along the central axis direction of the tube (11) (syringe (10)), but, for example, it may be extended in a direction inclined with respect to the same central direction. The shape of the through hole (34) in the longitudinal section is not limited to a straight line and may be, for example, curved or crank-shaped. The shape of the through hole (34) in the transverse section is not limited to a circle and may be, for example, polygonal or elliptical.

[0145] The shape of the first hole (34A) in the cross-section is not limited to a radial shape and may be, for example, rectangular or tapered at the end with a diameter decreasing towards the tip. The diameter of the second hole (34B) may be radial with a diameter increasing towards the tip, or tapered at the end with a diameter decreasing towards the tip. The expansion rate of the third hole (34C) may be the same as the expansion rate of the third hole (34C) or greater than the expansion rate of the third hole (34C). In the above embodiment, the maximum opening area (opening diameter) of the first hole (34A) is larger than the cross-sectional area (inner diameter) of the internal space (barrel space (15A)) of the syringe (10), but may be less than or equal to the cross-sectional area (inner diameter) of the internal space (barrel space (15A)).

[0146] In each of the above embodiments, the forming material of each member is merely an example and may be formed from other materials.

[0147] In the first embodiment above, a blood collection device (blood collection kit) for collecting blood (B) was exemplified as a collection device (specimen collection kit), but the collection device (specimen collection kit) includes a collection device (specimen collection kit) for collecting specimens other than blood (B). Specimens include, in addition to blood (B), urine, feces, sputum, saliva, or liquid materials obtained by surgery. Test items include infectious diseases such as influenza or coronavirus infection, sexually transmitted infections (syphilis, human immunodeficiency virus, etc.), etc.

[0148] The test (determination of infection status) used in the present invention is, for example, a visual determination type rapid diagnostic method. A visual determination type rapid diagnostic method is a test method that visually determines the presence or absence of diseases, etc. by utilizing the principle of reaction with antigens or antibodies in a specimen. Examples of visual determination type rapid diagnostic methods include LFA (Lateral Flow Assay) and RDT (Rapid Diagnostic Test). LFA is a rapid diagnostic method (immunochromatography) that allows visual determination of the presence or absence of specific substances by flowing a specimen (liquid sample) through capillary action. Examples of LFA include COVID-19 antigen testing, pregnancy testing, rapid diagnosis of influenza, and detection of allergens and pathogens in food. RDT is a test that uses a diffusion amplification method (also called isothermal amplification) to amplify nucleic acids (DNA or RNA) without a heating cycle, for example, and specific examples are the LAMP method (Loop-mediated isothermal amplification), RPA method (Recombinase Polymerase Amplification), and NASBA method (Nucleic Acid Sequence-Based Amplification).

[0149] The test kit is not limited to an immunochromatographic test specimen and may be any test kit used for the test used in the present invention. The test kit is, for example, a test kit having a test area in which specific identification information (marking such as a line, a change in color, etc.) appears in response to a reaction with a collected sample. Examples of the test kit include a simplified PCR test kit, a novel coronavirus nucleic acid test kit, and an influenza rapid diagnostic kit.

[0150] In the second embodiment above, a user terminal device (500), such as a smartphone, is exemplified as an information processing device, but is not limited thereto and may be a dedicated device (infection determination device), etc., equipped with a communication function in the reader (300). The notification unit is not limited to a display unit (560) and may be a transmitting device or a pronunciation device that transmits notification information to an external device. The camera is not limited to a camera (313) owned by the reader (300) and may be a camera owned by the user terminal device (500).

[0151] In the second embodiment above, the angle of inclination of the inner surface (236B) with respect to the bottom surface (234A) of the cartridge cap (230A) may be greater than the angle of inclination of the inner surface (234B) with respect to the bottom surface (234A).

[0152] In the second embodiment above, the infection determination process is merely an example. The control board (314) of the reader (300) may perform at least a portion of the infection determination process shown in FIG. 18. In the second embodiment above, the immunochromatographic test specimen was an immunochromatographic test specimen (P) having one control portion (Pc) and one test portion (Pt), but is not limited to this and may be an immunochromatographic test specimen having at least one of the control portion (Pc) and the test portion (Pt). For example, when the immunochromatographic test specimen has multiple test portions (Pt), the control unit (520) of the user terminal device (500) may set multiple test areas (Gt) corresponding to each of the multiple test portions (Pt) (corresponding to multiple different test items) and detect the presence or absence of a test line for each test area (Gt). By using one immunochromatographic test specimen and performing one infection determination process, the infection status regarding multiple types of test items (antigens or antibodies) can be determined.

[0153] When using a test kit, after loading a sample onto the test kit, a test waiting time (e.g., 10 to 30 minutes) may be required until the test result is reflected. Therefore, in the second embodiment above, the control unit (520) may initiate an infection determination process (acquisition process for acquiring (taking) image data) with the condition that, for example, the test waiting period has elapsed from the time the cartridge (200A) is inserted into the reader (300) (the "test waiting process" of S110 in FIG. 18). The control unit (520) may detect that the cartridge (200A) is inserted into the reader (300), provided that, for example, an input operation (such as an operation of a judgment start instruction) is performed at the operation unit (550) by a user, or that the control board (314) of the reader (300) detects the cartridge (200A) (or an inspection kit such as an immunochromatographic test specimen (P)) based on image data from the camera (313). The control unit (520) may change the inspection waiting time to a time corresponding to the inspection item detected from the inspection kit based on information regarding the correspondence relationship between a plurality of inspection items and the inspection waiting time determined for each of the plurality of inspection items. Explanation of the symbols

[0154] 1 : Blood collection kit 1A: Information Management System 10 : Syringe 10A : Medical institution 11 : Tongbu 11A: Terminal device 14 : Gap 15 : Barrel 15A: Barrel space 16 : Lure 16A: Lure space 17 : Step 18: Fantasy Part 20: Plunger 22: Gasket 24: Handle part 30 : Attachment 31: Mounting part 32 : space 33: Acceptance part 34: Through hole 34A: 1st hole 34B: 2nd hole 34C: 3rd hole 34D: 4th hole 35 : Male screw 36 : Front cross-section 40 : If you give it to me 42 : Protrusion 50: Public institutions 100 : Blood collection cells 200, 200A: Cartridge 202A: Cartridge body 210, 210A : Base 211 : Accommodation space 220, 220A : Cover 221, 221A: Connection 222, 222A : Camera window 222B : Protrusion 224, 224A: Chimney hole 224B: First flue hole 224C: Second flue hole 224D: 3rd flue hole 224E : Pressing part 224F : Pressurizing part 226 : Hook-fit section 228 : Contact part 230 : Eyedropper 230A: Cartridge Cap 231 : Cap sheet 232 : Receiving hole 233 : Plate part 233A: Protruding part 234: First receiving hole 234D: 1st protruding hole 236: Second receiving hole 236D: Second protruding hole 238 : Legs 238A: Convex part 300 : Leader 311 : Casing body 312a: First indicator light 312b: Second indicator light 313 : Camera 314: Control board 315 : Battery 316: Communication port 317 : Yeontong-ro 318: Cartridge storage space 318A : Insertion port 400: Management Server 500 : User terminal device 520 : Control unit 530 : Memory 540 : Communications Department 550 : Control panel 560 : Display unit

Claims

Claim 1 A sample collection kit for collecting a sample, comprising a cartridge having a receiving space for receiving a test kit and a receiving portion formed in the cartridge, wherein the receiving portion has a through hole formed therein that penetrates from the outer surface of the receiving portion to the receiving space, and the through hole includes a first hole that opens toward the outer surface of the receiving portion and a second hole located between the first hole and the receiving space, wherein the first area of ​​the cross-section of the first hole is larger than the second area of ​​the cross-section of the second hole, and the second area of ​​the second hole is smaller than the internal area of ​​the cross-section of the receiving space. Claim 2 A sample collection kit according to claim 1, wherein the first hole is opened such that the cross-sectional area expands from the side of the second hole toward the side of the outer surface of the receiving portion. Claim 3 A sample collection kit according to claim 2, wherein the through hole further includes a third hole located between the first hole and the outer surface of the receiving portion, and the expansion rate of the third hole is different from the expansion rate of the first hole. Claim 4 A sample collection kit according to claim 1, wherein the through hole further includes a fourth hole located between the first hole and the outer surface of the receiving portion, the fourth hole is opened such that the cross-sectional area expands from the side of the first hole toward the side of the outer surface of the receiving portion, and the cartridge has a contact portion that contacts the inner circumference of the fourth hole of the through hole over its entire circumference. Claim 5 A sample collection kit according to claim 1, additionally comprising a cartridge cap having a press-fit portion that is pressed into the through hole. Claim 6 In claim 5, the cartridge cap is a sample collection kit having a receiving hole for receiving a buffer solution.